BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23752977)

  • 1. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension.
    Zarzuelo MJ; Gómez-Guzmán M; Jiménez R; Quintela AM; Romero M; Sánchez M; Zarzuelo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Cardiovasc Res; 2013 Sep; 99(4):622-31. PubMed ID: 23752977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
    Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats.
    Zarzuelo MJ; Jiménez R; Galindo P; Sánchez M; Nieto A; Romero M; Quintela AM; López-Sepúlveda R; Gómez-Guzmán M; Bailón E; Rodríguez-Gómez I; Zarzuelo A; Gálvez J; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Hypertension; 2011 Oct; 58(4):733-43. PubMed ID: 21825230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Robles-Vera I; Tamargo J; Martínez MC; Pérez-Vizcaíno F; Duarte J
    Biochem Pharmacol; 2016 Jun; 110-111():25-36. PubMed ID: 27179975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5.
    Romero M; Jiménez R; Toral M; León-Gómez E; Gómez-Gúzman M; Sánchez M; Zarzuelo MJ; Rodríguez-Gómez I; Rath G; Tamargo J; Pérez-Vizcaíno F; Dessy C; Duarte J
    J Pharmacol Exp Ther; 2016 Jul; 358(1):151-63. PubMed ID: 27189971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
    Toral M; Gómez-Guzmán M; Jiménez R; Romero M; Zarzuelo MJ; Utrilla MP; Hermenegildo C; Cogolludo Á; Pérez-Vizcaíno F; Gálvez J; Duarte J
    J Hypertens; 2015 Sep; 33(9):1831-44. PubMed ID: 26147382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus.
    Romero M; Toral M; Robles-Vera I; Sánchez M; Jiménez R; O'Valle F; Rodriguez-Nogales A; Pérez-Vizcaino F; Gálvez J; Duarte J
    Hypertension; 2017 Apr; 69(4):641-650. PubMed ID: 28242713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
    Jiménez R; López-Sepúlveda R; Kadmiri M; Romero M; Vera R; Sánchez M; Vargas F; O'Valle F; Zarzuelo A; Dueñas M; Santos-Buelga C; Duarte J
    Free Radic Biol Med; 2007 Aug; 43(3):462-73. PubMed ID: 17602962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin 1 activation of endothelin A receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension.
    Chen DD; Dong YG; Yuan H; Chen AF
    Hypertension; 2012 May; 59(5):1037-43. PubMed ID: 22431579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt-Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats.
    Yao NA; Niazi ZR; Najmanová I; Kamagaté M; Said A; Chabert P; Auger C; Die-Kakou H; Schini-Kerth V
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):573-583. PubMed ID: 32187164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.
    Toral M; Romero M; Jiménez R; Mahmoud AM; Barroso E; Gómez-Guzmán M; Sánchez M; Cogolludo Á; García-Redondo AB; Briones AM; Vázquez-Carrera M; Pérez-Vizcaíno F; Duarte J
    Clin Sci (Lond); 2015 Nov; 129(9):823-37. PubMed ID: 26253087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
    Iglarz M; Touyz RM; Amiri F; Lavoie MF; Diep QN; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):45-51. PubMed ID: 12524223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.
    Toral M; Romero M; Pérez-Vizcaíno F; Duarte J; Jiménez R
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H189-H200. PubMed ID: 27881385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
    Capozzi ME; McCollum GW; Savage SR; Penn JS
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
    Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF
    Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
    Wenceslau CF; Rossoni LV
    J Hypertens; 2014 Mar; 32(3):542-54. PubMed ID: 24309491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.